OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Charfty R￿istratIon NO. 113485915C039721 Company Re8ftstratlon No. 071271011Ehgland arbd Wale&} REPORT OF THE TRVSTÉES AND AUOITED CONSOUOATÉts FINANaAL STATEMENTS FOR THE YEAR ENDED 31 OECEMBER 2024 FOR NATIONAL RHEUMATOID AmRms 50aETY

NAYIOIIAL PIELIMAT(MD ARTblRITI5 SIX LEGAL AMJ AOMIN15T41ATIVE INFI)kM411O14 Trust• MrR&th5 Mr S (olllns Mr R F￿4￿1￿•￿ Mr J Jw(twTr Profr5wr P Ti>r A Woolf Ms C WorKI MrPF(ryt UWTIW numb 113485915C039721 Cpnpiny numb•r 07127101 lJry151•rxl offl¢• ile 3, Grov0 Business Pf White W•ltham Maldefihel SL6 3LW Moorn Klhvtm Smlth lip Th• ShIpp￿t WhJlfi¢ Th• Old VITr￿ Faetory 8lyth llo•d U83 114A HS8C JS Hl&h Siy•¢l Mldenhe•d

RNWMATOID ARTHRITIS SOuFrY ¢OI¥TEv Trw1tt5' report Stri1[T￿l olTrLuws' rtSPQDslbSlitlB5 45 to 6ithur¢ ty pur 14 irvjqppndent tewE Cw5plldated Sratsftfti ol kn•TrFlol idlvlES' 19 Cpnwry StaterMAt ol ATr•rrW K¢l¥kn5 Cwbspndi¢d arbd CaAtyWlV 6•knncy Slkttt5 CpnsgW•td st0￿men1 ol Flvws 14ot*¥ IV 13-37

NAfioNAL RHEUMATOID ARTHRIT15 SOaETY TRU5TEE5' REPORT (INCLU0114G DIRE￿oR5, REPORn FOR ThE YEAR ENDED 31 DE￿MBER2o24 The TiLssles presènt thÈiY tÈport and auditÉd tonstsl#latÈd attounts for the year Ènded 31 December 2024. The Trustees hbve adopied the Pfovlslons of thÈ StstefThent of Recommende PracriFe1SQRP) "(oyntin3 an¢ BeponinE by Charille< IFRS 102) ID prepiriThs annual r¢wrt tsnancijl 5tatenEnts of the Charity. The accounts have been prepared In •ctoYdar•Ce the acctsuftiinÉ wllcles set out In nvte I to the acc9unt5 arKI x)mply wllh tbe Charity'5 8overnins dowmeni, Ihe Chariti¢s kt 2011, thè Ctsmpbnies Act 2(YJ6 and -Accoun1i￿ and Reporting bv Charities: Statement of Recommènded pra￿te applicablè to ctrKaritie5 preparin8 their accounts in acco¥dante with Flnantial Reportlng Standafd applicable In thÈ UK and Reputs1￿ of Ireland (FRS 102) (effetlivÉ Ljantsary 2015 a5 updaled in 2019).. Chales Report A w3 rm w@Icome to the NRAS annu31 report on behalf of the Board of Trustees. l am very pleased to report another successful yèar with Si8nifrtaht proyess In several directions. This is entlrely due to the dedication and Pfofesslonallsm ol Ouf team, both stalf and volunteers, whose hard work ofi behalf of all those livin8 with Rheumatoid Arthrltis IRAI and Juvenile Idiopathic Arthritis (JIAI has rnade a real difference. I thank you all on behalf of the Board. Flrstly. the Board welcomes our new thief Executive, Peter Foxton, who has taken over from Clare Jacklin followin8 her retirement after many years of servlce to the charity. Peter joined us in the Summer of 2024 followlng a rigorous sele(tion proce55 and brings a new perspectlve on the challenges we and all other tharities face thanks to his relevant experience in the sertor, latterly in income generatlon for Phyllis Tuckwell Hospice Care. Peter has 'hit the 8round nJnnin< and Is already makin8 a real impact, not least In the preparatlon of the new NRAS 5trate8y. This key document, whkh will guide ovr diredion over the next few years, has been based on extenslve consultation acros5 health caro professionals, our beneflclaries, volunteers and member5. as well as wlthin MRAS ftself and wll I be issued later thi5 year. Nationally the need for NRAS'5 service5 has never been 8reaÉer. The pressures experlerkced by the NHS have resulted in challengès a¢ross the board afid the impacts on theumatolo services, in terms of access and responsivene55, have been 518nificant. Our expertlse and atient-focused approach can Gomplement NHS 5ervi¢es ¢hrou8h the prov15ion of Inforrnation and support to both the newly dlagnosed and those who have been livine With RA or JIA f4r thahy years. SÈr￿1c*s such as Right Start. SMILE and the Helpllne ean make reèl dtffÈrenco to people'5 OUtcome5.

NATIONAL RHEUMATOID ARThRI￿5 50CIEr TRUSTEES, REPORT IINCLVD1fv6 DIRE￿oRs, REPORT) Foft THE YEAR ENDED 31 DECEMBER 1024 FlThincially, this has been a year of 50Jid performance. As predlcte<l in our budget forth year. In¢ome was down on 2023,5 record level. 8y tl8ht control ol costs ho4vèvÈf. ¢Ombined with very vJélcofh¢ in¢rea5es in legacy and iDve5tment irttome durin8 the second part of the year, we were able to flnish 2024 with a small Surplu5 after accountin8 for irbVe51mefit gains whi 1st maintainin8 levels of servlce throu8hout, Lc￿kIng forwèrd to 2025. thlThgs look PQSitive due to OThROin8 effort5 to diversify ovr iTrcome stfeams as well 35 3 si8nific3Tht 3-￿a grant frDin the National Lottèry recently awarded to help develop SOMÈ of tsvr service5. With an Increasin8ly divefsitied fundirt8 stream and the irnplementation of our new straie8Y we ère lookln8 to the fvtvre with conlldence. SimLTrn Collins Chatrof Tru51ees

NATIUNAL RHEUMATOID ARTHRMS SOClErY rRtsSTEE5' REPOR T IINCLUOING DIREcfoRS' REPOR FOA THE YEAR EIIIOED 31 OECEMBER 2024 Our purpose and actlvitles Guidancè from Ihp Charily Corrtrhi5sion h$75 been used to review and develop NftAS's èlms arKI Obj￿11¥¢5 50 thai attY¥itie5 I￿ Gleèrly focused ￿ derive 8ood public bÈThÈfit. IX>jEcttYe5 arKI a¢ii¥ltJs The obhects Cjf the Cha rity (the 'ObJerts"> are for the publlc benefrt ￿ promote Ihe relief of people Ikwlrf wilh R￿uMat01d Arthriti51 RAI and Jurfenlle IdlopathK Arthriti5 IJIAI by.. Raisins awa reness and urKlerstondlnE of RA and JIA, includin8 awareness of the severity of tl ¢i5eases and their social and economic costs: Providlrtg information on RA and J14 includin8 Inlorm3tlon on iheir treatments ènd drugs awa11 able; Adwanting all aspects of the care and treatment of RA and JIA and the man4ement of ihese diseases In their tofality,. Providing educatlon on Ihe di5ea5es 6eneralty and to Indivlduals and thelr fathllles arnl (areT5 in all aspects of RA ar•d J1& includin8 thelr treatment and rnana8emeni, and prowpdin8 inforniation aboLFt avall8ble support. SuppDrtiw individuals acrogs UK in relatlon to RA and JIA and their familles and urers, intludin8 pulling people In iouch with each other to encourage sell-help and support where approprbate,, WorkinE alon8Side NHS rheumatolo￿ health professiona15 across the UK to provide the best Ca￿ for patients as well as support the cJini(al stafl in their role& (￿r ¥ision and purpose 0￿r vtslon Is a future Whe￿ everyone with RA and JIA can thiiwe, Our pvrpD5e 15 to inlorrn and support people with RA and JIA and campaign for improvements io care ar•d tre3tments, We will achieve our ws•on by locusin8 on fgur rn•ln areas of work; Inform1￿ and Educatin8.' To greatly Increase underslanding of RAarNI JlAand numbet of people accessins our servlces S4JPPDrtin8 and Empoweri￿. to support more people to safely 5elf-rni n48e their health by improvin8 the relevancy, •ice551bility, vlsibility and reach of our serwices CampBlgnlng and Researth: to 5UPPOrt fÈsÈarth and rampal8n to impme aco55 io hl8h quallty carè •Thd tréètment5 Ralslng furK15 H rbd bullding a fèsil•ent 0￿￿niSatIon. to build a strong orsonI￿tIoTr ihat raises more mprEy from dlversÈ Stsurce5 lo meet the needs of paiient5 Our prlnrlwl Jctlvltles We are comm itted to prowpdifit upport, e￿￿enced-b&sÈd I￿￿{matIo11, 5eNlces, edL*atiofft. Caftlpaignins and paileftt advocacy of the hi8hest 9ual¥ty to, on behaFf of all, thosÈ affÈ(tEd by RA nd JIA i(rosS the UK as well a5 their familiÈS. We a159 SYPPOrt health pr0fÈ5SiDr￿ts in Ihe fleld of I1￿uMat0108Y and primary (ale th1o￿h thE provi5ton of free Hèaltkare Prpfe55ional rnemborship ol

NATIONAL RHEUMATOIO ARTHRrt15 SOCIETY 7RU5fEE5' R£PDRf IlNCIUOIN6 DIRECTORS, REPORT) FOR THE YE)J4 ENDED 31 DECEMBER 2024 OurfrfJnt.Ilne sÈrvicès inFlwle: A HÈlplirt Yihi(h operates 30 hours per week and Is Martag￿ by a team of four telPwuèl' An onllnÈ pepr 5UPPQrt community Local and virtual £roup5: A peei.tts.ppÈr telephone support programme: A supwrted self-mana8emenl modular ¢-learnlTr8 pro8ramme' Informatitrn booklpts. WebsitÈs packed with information and downloadable resourto4' PatiÉfii èvertts It￿th in person and virtually} A membèrship xheme Living wrth RA and JIA is not jusl about havln8 physical and medlcal needs. These incurable dlseèses have a huge imw on emotional vrellbeing Ind qvality of Ilft ¢M both the in4Jividual an(f t￿rr famity. We will continue io strfrve lo help peopk by suppori1￿ oll their needs In a holistic way whether phy5i(al. medical, emotional, mental, soclal. econornic and/or eff•plo¥ment related needs as well as thos relaiiw to access to beThefllS. We are èt ihe tabk at a nat5on&l level whenever standards and guidelines WJIA pathwaysand access to treatment are bein8 dtscussed, We conduct our own S￿la1 ￿searCh and publish k¢y reports on • topic of importarKe to people w¥th RA/JIA perlodlcally. Tran51alional scleniific arKI medical research h•$ revolutionised the fleld of autfrimmulle condlthjfis h as RA and JIA in the lasi few decades and whilst we do not fund mÈdical research oursel¥es. we do SUPPDrt a Erowiw nufflbe¢ of atadÈM•c and clinlul researth stud￿5 thrO￿hOul UK on an Ollgoin8 basls. We also support fecruitrnent to clinical studies and provide txpert VDlunteers to advlse on issues ol Patientand Publlc Irwofvement. We do on o(cas•on conduct our funded major social research slud*s often In partner5hlp wlth an academic Instiiuie. In 2024, we continved Ehe deveh)prneni of our suite of e.leamln8 self.management programmes, dev15ed and prDduced by our fourmler and now National Patieni Champion, Ai15a B05worth MBE. WE ha￿ a total of Seven modulés fiÈély available for anyone to acce￿ on our websile arbd work h45 now started on OLpr largest a nd most complex module to date, Cardlovascular Disease Risk Mana8ement. In 2025 we plan to start WQfk on de￿rning a range of short vldeos to complemenl Ihe modules already avallable. These VTrdeos will aim to present thÈ key his￿1¥ht5 from of our mcKlyle51Tr In informallve way and will accesslble on variety (Jf di811•1914tforms. We a150 plan to run an awareThe55 campaign fo eniourage even more health professionals to utili5e the SMIIE modules for patient edu(i lion by signposting people liviTrg With RA to register foi the progfammè.

NATIONAL ftHEUMATOID ARTHRrnS SOOETY TRIJSTEES. REPORT (IIICIUOING DIREcfoRS' REP( FOR THE YEAR ENDED 31 DECEMBER 1024 Nrf Income totalled over£l.$4ffl How we raised our money £n8.Th £45J.4 £22S.9k 11 £59,Ik 00N￿> arrfl lifts Clwiiable •ctfvths Oth•r Yxoffl• • 102J • 2014 11 was gothg ts b• • Ch to ropkakn t a)corn• i•v•ls a￿j w il Dv•d 10 b• with over•1 wKorM dcyn 17.5% ￿ 2023. The yearfs perforniance was 48•ln dofflinated by legacy bequests where reported Incon ￿l¢l￿d £788.7k, representiw 0￿1 51% ol the Charivs total income. Whilst this rewlle(I le8acy IncorTre wa5 a drop of ovtr 2496 on pnor ye4r li vi45 ￿111 our secorKJ-be5t lesaw perfomiance ever and rpflects the trend we have seen in recent years for larger individual beqtsests. We tEtnain immensely grateful to our very Benerous bÈnÈlattots whose gifts enablÈ us to coniinue to lftvest in Our servTce5 and deljvei new irtrtOvation5 which are 50 needed especialty ès we Ènièr a hèalth environment rrO(e focussed on deliverlD8 servkÉs dpgitally. Irptons and partrbefships knITth pharmaceutical cornpanles ta¢pfully and work ¥vlhin thÈ atcepted wde5 of practiCÉ SÈt down by Ihe A550Clation of thÈ BritA5h pharMa￿uL1¢al lTrdu5try IA&pi). As well as hèlping to fund the cole serwitÈs that v*e deliverfo our bernÈficiarie5. Ihese relatlonships Pri>vide NRAS wlth access to irtlportgnl jnforyDaiion I boui clinital trlal data arbd hÈlp tts infvrm an¢ edu￿te otsr team membe[5 on RA and JIA, AS a keyexFYrt partner

NATIONAL RHEUMAfoiD ARTHIUTIS SOCIEr¢ TRUSTEES, REPORT Iit4CLUDIIIG DIREcfoRS' REPORn F(￿ THE YEAR ENDED 31 DECEMBER 2024 NRA5 conEribute5 to advisory boards ahd employee iralnin& as WÈH as PTovidln8 SUPPOrt In the de¥e￿pfftent of their Own patienl-tacin8 5UPPOrt rÈsources. The Clbarity also operates a mÈmbèTship Scheme for those Ilvifit with RA or JIA their famllles and health care piOfÈss￿n3[S which provides access to a mernber< forum. monthty new5Petters and a b anp)ual magaiirbe full of intefesiirrf article5 and informatlon. IntomÈ from the membership Kheme totalled £81.3k In 202412023: £85.4k). Support for NkAS wès al￿ rècewed thro￿h 8lallts from trusts and found3tiorFs afid in 2024 thll amountetl tel EID5.3k (2023., £72.6k), répfÉ￿rttlntt a 45% increase. We V4Ould like to expre55 partitular tharbk5 to the following organisations who all donated £2.(XK) or over: N&t10r￿1 Communltles Loite¢￿$ Fund Awards for All Ewlahd. National Lottery Community Funcl. The Plational Lottery - Award5 for Ail Scotland. Edith Florence Spencer Memorial Trust, The Frank ￿t(br*I￿ General Charitable Trust, The Millenium S¢adlum ChartiablÈ Trust, Th¢ February foundat￿, The fjrKe Trust, The Vande(Yell Foundatlon and The Eveson Trust. We continue to work with aiademic partners, phlmiaceutical cofflpanles of ot￿¢ oi£anisatiOns i the flelrl Df social research to help dévelop and deliver new servlces to best meet the need5 of all Ih05e we serve as ¥véll as campai8n to effect change wlih governrnent. the NHS and thDse who commiSs￿n healih and Social care service& In 2024 income 8eneraied from research activilies toi•lkd £16.Ok {2023: £29.2kl. All lTrcome receywed throu8h furKlrak51ng In 2024 contributed io enablln8 the Charity to provide a full P(QEramrne of resources, Ictivitles and support which be￿ffits those living with RA JIA In the UK. their families, schools and the healthcare pr4)fessiOruls who care for them. NRAS w¢uld lik t acknowlèdgè and thank all the Indlvlduals. companies, trust5 a nd loundations that have supported our work this year,

NAnONAL RHEUMATOID ARThRms SOQErY TRUSTEES. REPORT IINCLUDING DIRECTORS. REPc￿￿ FOR THE YEAR ENDED 310ECEM8ER 2024 T1￿ expendltufe totolled £l.57m (heral ex[￿nthr• yOOf weag•d ty 2.9% ￿ £1574m. Of lh total am￿rt £304 7k w spthit M raising funds to £348.Ok ￿ 2023. A total 01 £1.269rn (2023", £1. 182m) was swrd Money spent on charitable activities f438.0 £385.4k UJO.2k £1￿.4& £71. 11 people •202J • 1024 Avern8e full.tlme equfvaleni employee rwmbers totalled 26. urKh•n8ed Since 2023 wlth employ￿nt costs I￿n& by 3.2% reflecti￿ an￿•1 c051 of Il¥k¥ Incrase5 awarded to all sthfl. The Ch•rty rnported a con501bdate<l Mt surplus 01 £26.C in 2024, down froffl £403.9k in 2023. The Charivs wholly owned Iradi￿ subsidlary. NRAS Community ServKes Lhmited, was largely donTh•nl hi 2024. ￿ cofflwny reported • nil net wofft on its actMts In 2024. Net aS￿ts in Ihe ye4r Incre•sed by É26.Ok ￿tre￿inG., fjains on revaluatiofi of investments of £S8,5k, rep¢èsèrtting a 5.8% 8rowth In the fund An incre4se of £212.Ik on cash at bank and short lerm irNÈstments A reduction of É2H,6k on lixed as5Et5 4nd other current assets. primarity refle(tlnB Ihe re￿ase of accrued le8acy intamÈ.

NATIONAL RHEUMATOID ARTh￿nS SOOETY TrUSTEES' REPORT (INCLUDING DIRECTORS. REP(xn FOA THE YEAR ENDED 31 DECEMBER 2024 Unrestrlcted. undesiirwted reseThes at 31 December 2024 totaNed £1,098. 112023." £1,397.4k) Ivini rise to an operatiry cost coveray 018.37 {2023: 10.96). The Ch4rltVs reserves polky requlres fvt It holds a mlnlmum of slx months. operaiin8 costs In reservts which at 31 Oecember 2024 amounted to £787.Ok12023.. £764.%). This leaves free ￿serveS a5 at 310ecembef 2024 01 £311.Ik {2023'. É632.Sk). Frtr reserves a￿ defined •s unrestricted funds which have not been eanMrked and may be use(1 seneralty io fvrther the c￿ri￿$ objectNes, A5 in Pfevlous years. the Charity contlnues to set aside de￿nated re5efves io wpport the continued delivery of its cole serykes for the upcoming p2riod and also io cover ￿tentIal inve5tment105sek These desl8nated funds in aggregate amounled to E475.2k as at 3 1 DKember 2024, The Board has 48reed to set aside additional funds thls ￿ar whKh will be desl8nated for servKe development I£2￿). extensive awareness raisir% campai8n5 (£IC)kJ ind an estate development fund (£IIXlk Ixlrqlw iotal desi8naied to £925.2k. How our unrestricted reserves are allocated 2,Ci*).IX¥) 201J 2024 We wlll hard to enswe that our fvTrds •re used $0 that we feturn the bl8gest benefft to ¢)ur beneficiarles for each pourKI Invested. We will Contin￿ the expanslon of our services to rnake t￿ffl more Induslve. broaden our d¢ital offerlny a5 well in campal8ns to ralse awareness of RA •nd JI Golry con¢trn Our healthy cash balance and invellment Portfol￿ means that we hm Suffielent Ilquidity to enwre that we can meet our futurt oblytion5 as they becoffle due lor the ft>reseeable fvtwe.

NAfioNAL RHEUMATOID ARThftITIS S￿Ery rRU5tEES' REPORT (INCLVOIWG DIRE￿oR5, REPORTI FQR THE YEAR ENDED JI DeCEM8ER 2024 F￿ndraIsIn£ pra¢11¢￿$ ThÈ tharity complles With thÈ re8ulalory sfandayds for hjndra i5iry. We are rÈÈisterèd with the FuThdraiSine Regu13tor arbd are comfftitiÉd to the FundralslD8 Promise and adherence to the Code of F￿nd[al51￿8 Practi￿, Thls report covers the requirements Iharitl¢5 111115t follow as set DLIt in the Charifes Acl 2011 and the ¢hariiies Social and Protettion 2016, Our fufidiai5ing effort Invofves Ér￿ur￿inE donations through a variety of events, apolyihg for fund5 from Erant-rna klnE bodiÈS vperatin8 a weekly lottery. Our ftyndralslng tÈam tofnprise5 paid employees only and we do nol use ihe Sèrvi￿5 of èny pr4)feSsio￿l ￿nd￿lSer5. ￿1 dlrect marketins Is tsndErtaken by ihe fuftdraising department to eftsure that il is not unfeason4bty intrusive nor petSi5tent, All rn3rketin8 material ffjntalns clear instruction5 on how & person can be removed from malling li5t5. We operate our lottery compliantlw under licen￿ from our local autknityand all admlnlstrauort is handled by a certified Exiemal Lottery Marw8er wllh the Gathbliry Comrnlsslon. OtJr website outline5 Ouf complalrtts policy lor the publlc and clearly explains how an Inillvidual carb Complain. We received no complaints thts year lft ¢lation to fundrats4n8 artivlllés. We have published 04Jr vulnerable persQns policy on our websire. ITr addition to our poliry we hlve aTr agrttd operaiin8 procedufe to Pfotect vulnerabSe people. Our fvr)dfaisers. who are all paid employet5. are familiarised with ihe code olconduct to ensufe that it 15 appl￿d properlv. Invtstnient Polky •nd Oblertlves Longer.ierni isseis afe irwested wilh ihe alm of ai ￿ast maintainlry the real value of c3pltal11.e. a8alnsl inflation) within In appropriate risk Profile. The Charlty's investment obJeclive5 ore to invest lor the Ion8-term Ifive years plus> in a diverslfied portfolio en5urin8 that there is sufficient liq uKlity •￿il#ble to fund any 5hortfa115 or unfunded commitments. Investment5 are rnonaged by external professional fund manager5 3$ permilted by the ￿levant a(t5 ¥nd the charity commission guidelines. The Charity aifft5 to be a responsible investor and Ils professiona l fvnd managers are expected to take accouni of Envirtsnrrbental. Social and Governan {ESG) i55ues In thelr ihvÈstment analyst5 and decisionrnakin8 pro<ess and to Èngage with tf1151ees when appropriate, inclvdln8 Ihe prowisron of pefiodic reports covering ESG i55ue5. Investment perfomiance report5 are recelveé quarterfy from the fund managers and tF TTu51ee5 review porforrrbonre annualty WFlh fund rnana8er5.

NATIONAL RHEUMATOID ARniRITlS socIErY TRIISTEES. RÉPORT IINCLUDI MG OIRECfOR5' REPORT) FOR THE YEAR ENOED 51 DECEM8£R 2024 Futurr pl¥ The TfuStee5 approve and adopt strategic ptsn5 for thÈ Charity every ihiee years detailpd bud¥e15 are prepa￿£1 annually to support thÈsè initiative5 derfio•)*trate how the objectywes ￿11 be cFelivÈfÈd within the Constra5￿t￿ of prèdicted fundln8 available. The bud8et15 reviÈwÈd on otsartEfly basis a nd èpprop¢iafe rnana8ement detlsitsns are taken In118hi of arly material fore(a5t varlances. ThÈ Charity IS currently finèlisins 115 Strate8lc pla n tovèiing 2025- 2028 byhith wlll set out how the Charity alms to increase its reach arKI be able to offer 5VPPOrt and advice to rnore dlvtfse communities. Worh Is already undep•vay to extend enhance our 5ervbce provision IQ improve awarentss ol RA and JIA In the wldÉr community. WÈ Èxpert to contlnue to work CDllaboratrwely to ￿mOve barriers to belw ible to acces5 the ri8ht treaiment. 31 the right time in the rl8hl place. provided by the rlÉht profe55ional. We wlll conliThUQ to work to red￿ce discrimlnation within the workp14ce ènd the wider society towards people with Inflarnmatory arthritis. We will also champion ihe best eY￿enCe-baSed healihca re provision no matler where in the LIK someone lives arbd we will support all those who work wbthin ihe hea Ilh Servi￿ to provide the best holistic care without bein8 hampered by a sysieffl with prevEn15 thern Irom a<hievin8 th45. 5trutture& 8overnBnce and management G¢¥ernlng document The Charity is controlled by its 8overnin8 documents, the memgrandum and artlcles arbd constitutes a limired by 8uarantee company as deflned by the Companbes Act 2LJ)6. The Charity15 a compa ny Ilmlted by guarantee and does not have any share capilal. None of the Trustees has aTry benefKial Intefest in the company. All of the trnstees are rnembers off the cornpary and guarantee to contribute El each in the event of a winding up. Trusteès The TrI￿e¢s, who ire also the direciors foi the purpose of compary law. and serwÈd duri￿ the year4Trd 10 the date of approval ofihese attount5 we￿. Mr R Bains Mr RA B0￿Cher ¢rési8ned 18 M•rch 2025) Mf 5 Collin5 (Chair) Mr R Flwerdew IDÈputy Chair) Mr J O Jordan IT￿45￿rer} ProfesxJrP Taylor Ms C Ward MISAW￿l( As set out in thp artfrcles (as att￿￿dèd in June 2019), Trustees alè rpquired io retlie after thrèe years Fn Dffjre. A ret4riftg trustee shall be eli8ible for rÈ-Èlection_ Mrs Collins. Professor P Taylor 4nd V(s A Wooll ¥Yill all theref￿re retlfe from o￿lte at the AGM on if JufiÈ 2025 arbd will 5ee1 re.C￿CtIon. Id r S CDlltn5 will have Served nlne ye?rs at the lime of his retirement thi5 year but has weed tts io

NATIONAL RHEUMATOID ARTHRITIS SOCIEr TRIJSTEES, REPORT {INCLUDING DI RECTOkS' RÉPORn FOR fHE YEAR ENDED 51 DECEMBER 2024 stanl foT re-appolntrneni io eft$￿re thèt Ihere Gan be an effectlvè handover tts a new Chair In duè course. Tr1151ee lTrductiOrt artd tralniTrg rplew TrqJ>tees are briÈfÈd on their legal oblisatlons Ufbdèr Chafily law. the content of the constrtLJt afid d*tiSiDn-makin6 pr￿e$s. tho business plan and recent financial perfom)ance ol ihe Charity. A5 part of the process they meet key employee5 and other Trustees and may atlend addit￿nal, relevFJnt eKtemal trarnin$ a5 re9uired. Ory•nlsatlèn ThÈ ￿dY of Trustees conslsts of not fèwer than four and no more thbn t￿￿1¥ ifuStèes arK4 administeri thé Chi¢ity ih[ts￿h the Senior Executlves. Re14ted partSes aYKJ fov0￿ration with other <Y(anI￿tIOnS None of our trustees recelves reMunerat￿n or other benefit from thtlr work with the charity. Any onfteciion between a trustee or ¥¢nior mana8er of the cha rity with a Supplier or other pamr ￿lh v¢h4ch Ihe Charity tran5aCts must be disclosed to Ihe full board of trustees, In the curyent year Th) S￿h related party transaCi￿n$ were reported. Pay poly lor senlor st¥ff Remuneration for key management pefsonnel is benchmarked a8ainst the voluntsry sector and is Mt by ihe TnJstee& pay ol senlor staff is reviewed annualty Ind normalty increased in accordance wrth average earnin8S.

NATIONAL RHEUMATOID ARTHRITIS TRUFfEES' REPORT IINCLUDING OlftEtTOftS' REPORT) FOrtTHE YEAR ENOED 31 DECEM8ER 2024 R15k nMnaym•nt The tru5tces hove D rfsk maypagement xmiegy Inclvrflnq o loMtsl ITsk Evolu4J¢lon whlth Is corfed cvt eoch ytor. Ilisk Category F5Thancial perlormwnce and resllSence 5isfftifAcant reductitin in intom¢ 5tr¢gms cashf10￿ due ￿ economic cllrnate could affett future viabj'lity of the Charity Mitigation and A¢tlons Fundraising St￿tes¥ focu5ill8 on provlsh)n of regular, predlctsble, uniestiTded intOfflE stfeams Anfiusl budgèt sèttin& process and quarterly review5 With us on tish Ilows and firMr)Cing o(operaiioTral plan5 Monthly maTha8èment ac(Dunt5 ¥elaiFi key perfonnance indicaiors and reserves covera8e Protecufig the Charlvi •&sets Markèt fluttuaifrtirts taused by eionom• instability cou Id ne8atively Impact our investment portfolio and reduce the financial asseis available to the Charity. Irwestment pc•licy is set so ès to maintsin an appeoprlate and prudent risk strategy Investrnents are managed by qualified external advirs Mairrtainlng a stabje team Cc￿MpetIti¥e ￿¢rUItment markets resultin8 In hlgh levels of vacancies could impact our abllity to deliver our lull range of core servbcts and lead to over.reliance on kty membefsof the Rt8ular benchmarking of ￿mUneratIon packages to et)sure comyiilivè Within thè ch•rlty sector Contlnue to priorltise staff wiellbeing to maximSse retention Work continues on s￿￿¢5510n plannl IT Securlty Failu￿ to erb5ure Iniegrity and SLYurlty of data could lead to data Ioss or theft, poteniially resultiry in fine% ￿pula￿lo￿lI darnase and impacr dellve ofour tofe services Oata Intesr51y Ind 8overnance includiTr& GOPR Fiiluie io meei Our regulatory obli8ation5 could lead to fine&, repviaiional damage and impa delive of our core seNi¢ÈS Attrartlfi¢ and retalningTrustees Fwllure to aitratt trustee5 Wflh 4 ran8e of skills could affett the future viabllity of the Charity Engagement ol third party IT consuirants to manage our IT 5yStem5 and controks Appointment of third wrty data proiectron 5pecialistS to Ideniify and monitor risks and ensuie tampliance with Te8￿1&110n5 Continue to work wlth our nelwork of partners and Col￿agueS to identify 5Ullable candidates t2

NATIONAL RHEUMATLND ARTHRITIS SOCIErY TRusfÉES' AEPORI (INCLUDING DI REcfoRS' REPOIT) FOFi THE YEAR ENDEL> 31 DECEMBER 2024 Auditor5 In actardance wifh the compaftls artlclès, a re501ution prowsin8 thai MoorÉ Kingswn Smith LLP be re-appoinied as atsditoraf the CDmpany will be put ot a Genefal MèÈtin8. Trustees. r•spoThsibllitie5 in relwtton to the fln•Thclal statement5 The Tnjsrees, who are also the direttor5 of 14atk)nal Rheumaioid Arthritis S￿iety for the purwse ol cornpany law, are respon5trble for preparing the Trustees. Report arhd the accounis in accofdanc wilh applicable law and United Kingdom Accountin8 Standards Iurtiled Klngdom Generall¥ Ac£epted AccouThtiw Practice). Company law requlres Trustee5 w prepare accounts fof each finanoal year which 8ive a true 4Thd fairvlewof the state of affairs of the charlly and of the incomiry resources and applitation of resourre5. includin8 the Irtoft aNI expenditu￿ of the charitable ¢ompany for that yeir. In kKepari￿ these accounts the Trusiees are requifed to: Select 5Ultable accountlng policies and then apply thern c0ns1stènt￿, obse￿￿ the methods aThd principles in the Charities SORP IFRS 102): Make jud8ments and esiimaies that are reasonable and PTudenL' State whether applicable VK Ac¢ounlln8 Standards have been followed, subJe(t to any miterlal depafture5 disclosed and ewlained in the fiThanclal staiement5: arbd Prepa re the accounts lin tht going concern bèsis unless It Is inapprowiate to presume that tho charity will continue in operatlon, The trustees are ￿ sponsible lor keeping adeq￿te attountln8 records that di5cF4Jse with reasoriable curhcyal any time the financial posil•on of the charity and enable them to ensure Ihat the accoun15 comptywirh ihe Companies Act 21VJ, the Charities and Trustee Investment Iscotlandl Act 21XJ5 arwj ihe Chlfities Accounts IScoikThdl Re8ulallons 2006. They are a150 responsible for 54feguarding the assets of the charlty ond hetKe fof taking reasonable step5 fof the prevention and (J@lecE•Dn of fraud ind other irregularities. The truStèÈS a￿ ￿5p￿rIs￿b￿ for the mainteThaThte and intesrity of the c4rporate and finantial nformation Included on ihe chaTitable compan￿5 website, Legislalion in the Unsted Kin8dorn 8overning the preparation and d155emlnation of financial staternent5 may differ from legislalion in other jurisdictlQn5.

NAnONAL RHÉUMATOID ARTHRITIS SOCIETY TkUSYEÉS' AÉPtsRT IINCLUOING DIREcfoRS' REPORTI FOR THE YEAR ENDED 31 DECEMBER 2Q24 stpi¢menl •¥ to dlxlc•yJ*e to èur auditOf5 In SD (ar is rhe trustees arè a¥•arÈ at the time of approving Quf TTUStees' Jnnual iÈportr. There is Tro relevant inforlnation. being inlormatlon needed bv the auditor in &)nnÈctiO With prtpafing their report, ol which the 8roup'$ auditof is unaware, and The tfQStees, having made enqulrles ol felbw t¢uslets and the group'5 auditor ihev OuEht to have lTrdlv•du•lly takÉn, havé Éèch taken a115teps that bel sh¢ h5 obll8ed to take as a Irusree, in order to make themselves aware of any relevant audit infowmation and to e5t3bli5h that the iudllor Is aware of Ihat irtfofmation. The ifvsteés aré responsible fgr the malfttenonce and inte8tity of the iorpor3te ancj finandal intswmalion included on the charIlab￿ tompany's website. Legislation in the Uniled Kln8d&m 6ovemln8 the preparètion and di55ernination of financial statements may differ from le8islat•un i other iurisdictDDns. S Collirts c￿air of Trustees J Jotdaft Treasurerl Trustee

NATIONAL RHEUMATOID ARThRins SOClEtY YRUSTEE5' REPORT {IPICIUDIN6 ts1 kÉttORS' REPORn FOR THE YEAR ENDED 31 OE¢EM6ER 2024 Oplnbn have a4Jdlied fthan¢i#l slment5 of Nallonal Rh8tsmalthd Arthntis S(Kiety {the 'p¥ent charilablÈ Tr)ryany') and its subsidlary 'gtOup') fr>r Its yew ended 31 D￿4￿M￿ar 2024 which (wrlse Il>e Consolldatèd Ststerywl of Financial Actlvltltt, (irtludin9 the Consdid?ted S¥mmry IncomÈ 8nd Expendrture Accotsftl). thè Grtsup and Parent Charitable Cornpany Balancè Shèèts. iP ConsoJKlaied Stalèmmt of Cash FI￿￿3 and notes to Ihe flnanaal &tsteffients, induding 9¥n￿cant atCOLtnb'rtg ptslic>ps. The financial reporting Irarrtework thal ha5 tjeen applied ￿ Iheif wepara1kJn is p￿￿rable Faw and Llnrtéd KirtQdom Accoun￿9 Standards, Flrtancial Rewrfin9 Standard 1 The Financial Reporting Sta￿￿ard appii¢abl8 in UK and Republic of Ireland (Untted King¢Jom Generally Accepied Accounting Pract￿e). ID our opinion th8 fiftancial $taÈwnts". rve a true and lair vh7w af thè sEal• ol Ihè )r￿P,$ and th¢ parenl charilabl• ¢ompaty'$ affairs aB at 31 DeCèrn￿r 2024 and ol the group's incoming cesourtes ond aPpkati￿ ol resour￿1, Ir)clLKfiry its incon 6XPèhdrturè. Ihè yèar Ihen e￿Jed. have been propefly prepared ￿ aCcorda￿e wilh United KlThJdom tsèftéfaty Ac£eptsd Aceountiflg Prac￿￿, and havè bèèn prepared in accordance vnth the Companles Ad 20￿. ts Charits 4nd TnJsi•8 Iryvestmenl {Scotland) Aet 2005 {as athènded). re9ul8lions 6 and 8 01 th• char￿8 Accounls (Scouand) Regulalions 2006 las amendea) and thé Charrt)ès Atl 2011. 8a81• lor oplnlon e coTrducied our audrt In accordance with Internat￿• sianoaiés on {UK) IISAS (LJKI) Bnd appk4tA8 law. Our respons￿111￿.es under those standards are furthL¥ descnbed in tho Audrtorf$ Re3F4)n￿Illie$ lof ihe audrt of the fmancial slatements sectt)n of oui re[￿l are indÈpendent of Ihe Gh¥iiabfe conwany in accordance with the ethical requirements 8re relev8nt to (Mjr audrt of th• ffinarwl Statements in the UK, IrtludirvJ the FRC'5 Eth￿1 Starhaard, and we have fuinid our other 81 responsI￿tEleS in aGG0rdan￿ Wih these reqvJr•ments Ive Lbeve that the wdrt ewdetKe have oblained i¥ ¢ufvSpffli 8nd apFKopnate to WOVKle a basis fry our O￿n￿Jn. ConcluBlon• r•l4llng 10 goSTrg Gonurn In avdilirg the fingnci81 t¢￿￿ts. we have concluded that the trustees. uae of the swjins ￿l￿ern ba618 of wJuniiry in tho prepatstson of th¢ fin￿¢1?1 staipmwis 4$ appfoprlats. Based on the work we hawa wrformed, we hpyg nol vjenif￿￿ any rnateftal UnC8f13inlies robting to eve47ts or condilrons that, indiv￿UaIty or collectlvety, may cast s￿nIfiCp￿I doubl on Ihe group's and parertt ch8rrtable company's atsllty to continue as a goir¥ concwn for a perb)d ￿ al lÉast tl¥e nK>nlhs from when Ihe financial slment5 are authonsed lof issue. I￿r reswrbsibilibès the Iw￿¥1￿.11ts.eS ol the Iru8te•s wth respèct to g)in9 con¢errb a￿ degCTiberS in ¥pYant seclions 01 thls r8pofL Olhèr InfDrnl•tlon Thé othw intsrrnptic>n comprtses the Inf0m￿liOn inthdÉd in the ?nny?I report oih8r than the finantial stslements and OUT auditorfs rppcKI thereon The trustees are respornsible ts Ihe otyeT inlornkBliOll Otltsinèd in the annual reporL Otsr opiThlon the finangpl slptemenls does nol co¥or thè cthèr nlDtnation and. èxeèpl lo Ihe pxtent otherwlse explluty slated In our re￿r( we do n(* ejprpsg any m tsf CAy)clusion Ilwoon. 15

NATtONAL RHEUMATOID ARThRtTIS SOCIETY TRU5TEE5' REPORT {INCLUDING DIREUOR5' REPORTJ FOR THE YEAR ENDED JI DECEMBER 2024 Ouf rèad Ihè othér ￿k￿rnat￿l and. h) dem￿) Èo. whé￿￿1 thè Offtéf t]rrnHIiDn iy m¥teriplty inc4yt5i5tenl wilh Ihe tr￿￿1a1 staiemeTrts w ¢Jur krhJwl¢dge obtsined in Ih urse ol Ine audrt or Oihep#ise appeafs io be rnatulially ml$staiÈd. If we Klèniify SL￿￿ mai8ftai Ir￿n￿en¢19S or apparpnt material mi5state￿￿nts. we we required lo 4JetPfmine wheiher there iy M£￿[181 M￿StateMent in ihe finan￿1 statsments themsefves. 11, bagéd on thè w￿k w8 pèrfonii8d. WB thHt Ihw? 15 8 mBterial mi55tstenwnt of thiy otrr infonnBD'on. we are iequirpd to thai raci. We have nothing to fepNt Irb thts fegard. Oplnbons on oth•r matters prnscrlb•d by th• Companl•s Act 2006 In otsr orAnion, bas•d on work Uftd8rtakén In tho ¢A)vrs& ol thè audlt., Ihe information 9Nen n the truglees. annual report fw the financial year ft)r the finanGial Stat￿ents are prepared is conststènt fIn￿C￿l staiements,. and p trustee¥. annual has been prepared in acwidwKe with applK4bie kga] reqU￿￿￿nIS, attorn vn whkh wp arn rn4uired to report by exGeptton In Ihe light of Iha knowl&Jge and understanding group and pMt ¢hartsbla cornpafty and the onvri￿rnenI Obtair￿ in the courde of the audit, we have not idenirf•J rTratef￿1 misststements in the trLrttth$' arMu¥ reporL have nothing to r•F)Ort in rnspect of the foll￿1r￿j mallws th• Companiès kt 20(￿, the Charits Accounts {ScollaThd) Regula￿￿$ 20C6 (as an￿￿Je￿) an¢J Ihe Charities Act 2011 require us to reptsrt to you rf, in our p¥ont Ch¥ti3b￿ comparry has keN adequate arKI s1ffK￿t x£4wllng reC￿d9, or ieiums adequate lor audit have not been rec•iAI from branches I￿4 vlsll•d by us" or Ihe p8renl charilabk companys financial stalements we in a91•omenl wbth tha accouThVn9 r•cords and returns,. or certain di8clo5ures of truste•s' r•mtsnorat•on spxifièd by law ar• not rr40o: we have receNed &ll the and explana￿0￿$ we rewire tof Ouf audrt,. or the trustees w¥e not entrtled to prepare the finarKial stslements in accordance with the irnll corrpanitis regrn and lake •dvanta9e ol the sTro11 cwipans exeffloKn In preparing 1 A4$iee$' report and trom we6wiry a straie9K repo(L Rpgpormlblllgles of tr￿￿te•8 A¥ eKplgined rtxye fvlly in Ihe trustees. ￿9p￿SibIl￿￿S statemenl sel Out on pagè 13. thè Irustees {who am also the dirèctois ol the charitable company lor the Pufwses ol cornpany lawl are Tesponsible lof prep¥alton of the financ￿1 5tsteNEnts belng sati5fiens. or h4ve Tro realisiic altem1￿.¥8 but to do 3Q Audltots R•Bponglbllrtle¥ for the •vdll ol th• flngn¢lwl rytstoffjom tye have been appointed 85 auditor Secb'on 44{1 Mc) of Chpaitie5 and Truslee I nvÈGt￿￿nt Isttooand) Act 2Q05. Companies ACI 20￿ and SdJon 151 of the Charn*s Act 2011 aTrd YrNJ in a￿ordance wth regulaiions made unde( those Act5. 16

MATIONAL RHEUMATOID ARTHRITIS sooÉni TRLisfEÉS' REPORT {INCLufAN6 DIRECTOftS' REPORn F¢￿ ThE YEAR ENDED JI DECEMBER 2024 {￿r Ire to obiain rèasonabte gyJyrance about whtthèr IhÈ f￿￿claI 5t¥lements a5 a wh are IrÈé Prom rhatenal nkt55t4iemeni, wnethèr duè ID ftaud or eftot, and to wue an auJitors tetjort Ihal h)dudey (wr opinion, Reascnab5& assurance is ¥ hBh level of assu¢an¢é. bu1 is ngt g 9ygrEntep thai an dkl cond(pCtèd in attcwd4ryn¢e Wilh ISAS (UK) wlll ahyays det g mrial Misstaten￿nI when rt éxisls. Mis5tatpmEnt5 can arise Iroth fraud tsr orror are matefiai rf. individually in Iggr4ats. they Coulcl rèasonably be expetsd io Influence thè e¢onwwG ￿￿1$1004 of u¥ers taken thè batsi5 of IhesB final￿1￿1 slalements. At of an 4udrt In accordarté with ISAS (UK) we exerclse prolttslonal JLKIGennl * rrpiniain professional SCePb¢ism throu9hout the audL Wé also: Idenikfy and asséss ts risks ol rnalefial misstalemefit ol IM hnan¢ial $talwt￿, Wh￿tI)er dwJ ta Or error. design 4nd perform audil procedufes responsive to Ihose flsks. and obt8 audlt evKlence Ihat Is SuffiC￿nI and apwopn8te to ￿0¥￿Iè a basis for Quf opinion Tr rLsk ol r•Di détecting a misstatement rèsulb'ng from fraud is higher than for one resumih9 fTc>m ror. ag fraud may Involvè colluwn, tsgery. intents'onal onwths, mi$opre5eniBlions. or the ovérnld• of ￿ternal c￿trOl Obtain 8n uftd•rsiandln9 of intemal control relevanl to ts audlt Its ordey to deg￿n audit proced￿re5 thgt are appropriate In the orcumstances, Iwt r)ol for Ihe purpo8•s of èxpf8ssEiig on the ell•¢tlvertess of the group and parent ¢harhabl• ¢empany's irtorn81 GoThtroL Evaltsalè thè tpproFYiateness ol accounting polK¥es Lued arKI the r8asonatrAené&s or accounbn9 esllmaltt and related thsc103ure8 made by Iho trusteès. Coneltsdè e>n the appropriateness ol the twstees. use of the goiTrJ concern basls of eounlln9 and. b88ed on thè aLrfJIi évrtjen￿ obtaiThed. whether a rrotefial urKerlainty exists reLthd tr) events or e<4nditiMs that 819nrfanl doubt on Ihe group and pafent charitablg company's ability to co￿nue as a goffig concem, If we conclude that a hlalerial uncertainty exisls, we ar? required to df3W attentlon In Our audrtorfs tewrt to the relaled disclosures in tho financ4al stgtemenls or, Il such disclosures are in•dequalÈ, lo mcKJify Our ownion. 04r conclusions are based ￿ Ihe audrt eV￿enCe obtained up 10 the date of 4Jur 3udrtoV$ repo Huwever. fulure events or conditions may c8use Ihe wp or paTenl Charita￿ company Gea5e k> contsfi￿ as a going conGem. EVaIL￿te the r)v￿alj pr•s•n&ttin. Struciure and ¢ontsnt of the IInanc￿ ststoménts, inthdin9 the dkscbsw•s. and whether the fina￿lat s¢alements f•w•s8nt thè undetying tsws&tK)ns arml •¥enls in a nKqnner ihai ac￿¥15 far wesentstion. Oblan sufficient apprDprwte aLKJrf evidenc• regarding thé fina￿181 Mirom￿ll¢n of the busitie5¥ ￿Vrt￿3 wdthln the group to exp￿$3 w opnJn on Ihe conS￿dated finana81 ¥i&ternents. ￿ are responsitrAe fof the direaion. sup8r¥ision and perfiymwGe QT the gfoup audil, Wp r¢rnB￿ solety fessx)n&ble lor our audit re￿)[L Wtr communi￿le ¢ho%e thargeé with 9oYemanGe Ip9w¢I￿g. ?mw9 Other mallers. Ihe ￿nned cope and It'ming of Ihè audrt and S￿￿[r￿￿nI audll findsngs. Including ￿ swnrfr4nt defveThxs in Irbtemal conlroj thal we i(lentify duri09 our audll Explamatltsn as to what exttnl th• audtt wat eonsld•rad ￿41p￿￿1• of d•ts¢tlng Irr•gLrlarill&, IncluJiTrg fr4ud Irregul4ritips, iTrcbJding fraud. lftstsnces of nonrycwpbance wllh laws and rÉav1atit￿s. ¥IVe pwocedurés in linè with oyr regponybtlities. outlinèd aboYÈ. to dEI materi mi55taiements In rÈÈpÈct of irwvlorities. l￿dud1n9 Ifaud. The exlpnl ¢0 which our Pr(￿lures ar8 C¥J of d￿e0￿￿9 regU1arrt￿$, iftcluding frBu¢J is detaiÈd below. Th& otJi•ctrvÈS Ot pvdil 111 respect ol Iratsd. arè. to idÈlltty Bnd ?gess the risks of matérial rrti&stslewt of the fina￿la s&tèrhèrtts dup fr4wJ; to obtain Sull£￿7t a¥4)rO￿.* gvKleFb 17

NATIONAL RHEUMATOIO ARTHRIT15 SOCIETY TR115tEE5' REPORT (I NCLUOIIIG DIRE￿oRS, REPO8TI FOR THE YEAR ENDED 310ECEMBER 2Q24 wegarding th8 aSSèSS¢d ri5Pfs gf rriatorFal miSstste￿￿nI due to fraud. throu9h <le5igning an InNJlEfiEnbng ¥ppropriate rèsFx)nse5 ¢0 those assessed risKS,' and ty respond appropKiai•ly10 Instart4 f fraud or suspèctèd trawl idenlified durlfla thè èudit Howoyer. the wmary tssponsibility fur ihe prÉtVéntwM and cleteclion ol Irajd rÈslB wilh l)oth ￿anagemen1 and thiw Gtsgrged wrth charilable company. Our apwoach wat as tollow5", Vve oblained an undÈrstsnrfin9 of the Wl and rÈgulat(ry requifements apPI￿able Its charrtablÉ company and considéréd that the rTW)31 si9Trificanl are th8 tompanw 2Q06, Ihe Charrties and Trnstée Investment ¢Scolland) Acl 21x15 (as arnended), regulatthis 6 and 8 or Chanl•tsS Accounts {Scodand) Règulalzons 2006 (as amended}. Ihè CharptiS Act 2011. 1 Charty SORP. and UK firnanc4pI reporting staThdards as ¢SLd by the FThnaal ReportirY4 Counul. W• ¢)btawJed widerslandlng of fvJw the chaniabl• company carnplies wth Ihe requirements by éISCussions with managem￿1 ar￿ those chary¥d with 9overnancè. aSseS￿d the n5k of rn3¢erial mlsstat8ffbènt of the financial statements. IrtIL￿1￿9 the rlsk of rnalwial mi55latemenl du8 its tra(Kl and h(yrt il rn￿ht oc¢ur, by IKldin9 discussions wlth mana9emenl and ihose char9ed with governance. We inqqjlreo ￿ mana9ennt and those charyd with govemance as to ary kntrn inslKee of ntrn-compliwtce or su$pe¢tèd non<0m￿.al￿e wrth l•VS and re9ulalion$. BBsed on this Ltndèrstanding, we ￿e$￿Tred s￿dfiC appropriate audil procedures to identify instances ol norkwipllance wlth laws aThd regulats)ns. This mcludtd rnaktng enou1￿5 of managerwi and IhM• charged wrth gwern￿¢t and ¢btaiThing addit￿n81 corrobwknv e￿Ie1bcO as r•quirod. Therè are inhereni liffli1a￿￿S In the audlt Pr￿edureS doxfiw abry¥e. ￿ are less Ilktrty to bacorne awwe of In$tarK•s ol rbo¢bcompl•n¢6 wlth laws and re9ulation$ Ihal are not cloMfy re181ed lo ever)ts and transacEion9 rellecied in the fin3nct81 ststements. Also, thè nsk of not detectlng a ffoterrdl mi8gterrTrent duo io fraud is ttigher than the ftsk of rKA detecb'rbg ￿e resulbng from efror. as fraud may Involve (￿lt￿rate concealm8nt ty. for example, forgery Of Itt￿nIK)n31 rnisrepresentaij'ons. or throuoh Us? ol ou¢ r•port Thts report fj made solely to ￿ d)8(iiable company's mÉmbeTs, as 8 txxly. in a¢cordancè wilh ChapEef 3 of Part 16 of compar￿ Aci 2C)6, and to the charty's twstees. as a bfrjy, in aCCofdan￿ wilh Sèth¢n 44{1)(G) ol the charrt￿8 and Twstee Invtstment {Scoiiandl Act 2005. and iospect ol Iho £onsoJld41ed finan¢Aal statemen15, In aGcordance wth Chapter 3 of Part 8 of thè Charilies Act 2011 . I￿r Audtt Ipeen undertaken so that we mghl slate kn the Chantsbk coffvbny's mernbe(S ArKI truslees those matter¥ which are iequired to sl to lh￿ m an audltor's report and bf ￿ other Puf POSQ. Ty ¢he ful¥i extent wnnitted by law, we Oo atr￿pt or as￿rre lespons￿Ility to any party ther Ihe chartsble ￿MP￿DY, the chariiable c¢mpany's ￿Er1e15, as a body. and the Ghority's In￿E8eS. as 8 boty for our aLMrt Wofk, for thi¥ rppgffL or for oplnion we haye fornKd. Luke Htstt (Seniw Statutory Audiior) Daty, 02k7/2D2 The Shipping Buildlng The Old Vinyl FatlDry Blylh Ro Hayes. London UB31HA for and on bÈh8if of Mpore K￿gStoft Snkn LLP, Stslutory Aud41of MDore Kirwjston Smllh LLP ig eli971)le to xt as a￿ditOr of SeGlion 1212 01 lh8 CA)rww AGI 2006.

PiATIDFthL ftXÉIIPMTOILI ARTHllln5%ICIETY COleOuDAfEP STATEMENT OF ￿tr￿￿lES IIThElthr4 lfvtOmE ￿1 É¥pvtwoA¢wwil FQFI YV4R Efw Ji oÉ(EMÉÉI 2 Tot Lknrthrltt•d Ilq51rl¢ TofAt nds 17•nds 1,141,7 191.7 14.5 1242.1 225,9 11,5 I,fyJi. 162,2 20.5 I￿1.) 210.9 11Tr.5 (hiriknbk ¥cthil 4&7 oo An¢ 15knK tho &0 L233 4 xo L269.4 L1>2.> 49. LIIL9 Yolal r•H￿rE•s 1.$38.1 741 4et belfft lrpltstff￿rts 13LI> IL41 132,51 33￿0 3XI rAO Gvo5S tr•rnsf•r% bttw Iw 0.0 0.0 oo oo Il¢t lur* 27A 40J.9 11 i Lg)7.4 2Qa L5￿1 11.51 19.4 L5 L613.5 0.0 I￿23.3 IW.4 ?￿17￿ Thi hWE5 13 ￿ IF f4XM Pwt ofthw 19

NATI(￿L SQ (<WAPANV 5TATÉMEPU OF I￿￿11￿5 (thKludlry FOR THE ITAR QrD 31 DECEMBEII Ioil Tatal run 2024 XOJ IQ23 L241.7 191.1 Ik4 U42.1 I,￿L% UA 1,601.9 OD OD 145 59J J4_7 14.7 1.5Q7JJ U7 5fj L169A L13U Llll 53•1 J&ts 49.6 iJi,11 [0.9 17A 2&0 Fyrkna •1 l J•J•ry lao L6141.1 13 L026.0 Tht st4temx Df •ryMlly Klk•es M PIAs&)d lomes r•trY￿ In lh• ye•1, The Sf*EErwrt OF I¥￿r￿[l￿ arth¥lw 0150 IhErniulrtmwts Ir

A YItspuL ItlEUMATOID •JETIftITty SOQETY ¢OP4s(X￿AT￿D OIAllffl 8ALA•¢E SPIIET5 Folr YHE YEAR EMDED 31 DECEMB￿ 2(124 Gf¥VAP Eharlty 2024 IgiJ 2023 Flxed •xsts lftuwlbk i55Vt5 T41￿ble a55￿5 15.0 13.8 J6.9 1.099.3 IPJ8.5 28 i.fiy>. J I.t10&5 1.131.3 IJIFIA I,1)1,3 IP71, Cuf¢ni SS•t5 Debrors 1$ 129.0 161.5 611.0 132,1 261.5 617,6 0.0 667.4 •t ￿ttIn IJX18.5 lJ)71.2 LU71A, u•￿1￿1." Q•drtor5.' fallkn$ witlaTr on• )wr 17 197.41 (125 2> 197AI 1124.71 Net t4¥rw 911.1 913,1 T¢l•l etsrrent Il•billtI•5 lJ>17,4 2M6.1 1,020.1 ljnrtstr￿Cttd fwb¢¥ estrirted Fmds 19 19 1023J 20,1 U97A 20.Q I,oz 2Q,I ILMI 2.043.4 017A 2,O46,1 L020.1 The Tntstt•5 Iwvt we￿red •ctounts in x¢Ordan￿ wlth se£tth 39101 the Cefflp•n￿ ILt 2IJKs Imd s•rtlon 13101 the cl￿rItieS A£1 1011 and rDTrllliufe the aNn¥al r•qUIr￿ Comwnles A£t 21ty26 4fid irè ¢kniliion to trustees ol the cornp•rw. Tl>M are prepfi￿d In att￿dI￿ wlth IhE sw(lalwo¥vJlord ol Part 15 C(W185 Att 2Iy)6 afe ( thwlilknn to the rrornbers o111 comp￿¥ Th¢ •t p•4u 23 to 37 lorni ptrt ot thHt •r¢ourt atecruAts w•r 4pprw•d the BD•rd olTrustrs on 17 ju￿1 1025 21

NATKJN41 RMEUMA7010 AmlRm5 5QCIErY CQI45QUDATED 5TATEMEtn OF CASH FLQW5 FOR THEYEAR ENDEO Ji fKcEMbER Gmup Charity ZQ24 2023 2024 2013 Cash froth opqTrilrn¥ Cash l￿d kn ¢per•iDQhS 19LS 358.0 194,1 359.6 In¥qstJni Purch15e of InT3ll8lble firfvd •ss•t5 Purcha￿Of tarwblÈ flxed asse Purchaseof 115ted Investfwlts Pwth)S of short twrn trrf¥StM¢nt% Interest reEviwed 0.0 (6.21 (32.3J (261,5) .0 14.01 0.0 16_2 132.31 1261.51 59.1 ,0 14.01 13Q,21 Net <•sh in In¥qstlni artl¥l¢deg 1240.91 {24Q.91 Net decfeast In rash and c•5h equlv•len 149.4J 3585 1468 C3th W•d e•sh equi¥aleTrts at becSnfilns olyew 667.4 C•sh 4Trd t*sh ¢wlv•l•nts at •Thd of ye•r 618.0 667.4 617.6 661A 22

IIA TKIMAL RHEu￿TOlD ARTHRms SOCErY i•trTES TO THE A¢C¢UNrs FOR T￿ YUR ÉhtsÈO 31 DECEM8ER 2fy21 MatlMBI Rhè￿￿1•1￿ Arilws $¢x￿ty IS & prkalè by ID Chartsts and Tr4¥fw Intrwlrrrnl ISo)w th12CQS. lh• CbarA8 Atojthlx R•]Wat]￿B 2[￿[0 4m&rbl&gl WLI "kn￿rry by Cl￿r￿S ol RK¢mrntndtd Prnfjbw lo cAurrth& I￿￿•1￿ Iher in w4h R•pwbrvJ SiwHlwKI •pplablè UK 4nd A•wlc ot IMl8rAY {FRS 102r. 4 Bvlrt Entrty ** d￿l¥ll ty FRS 1ryi ar• IL> the rc FwpBrtDès t> IncibJ• I￿1￿j fi¥￿￿18 arbj tsrtafft at l•ir v•hJ¢ Tr prw41 ac•xwbry PJI Prnpirllbon •1 G•n•trlIdal￿ fiwnchl slat•ffl•Trts Th•M Gonwha•t•d staiemrthls [man￿1 itsterrnts ol liw Chanty aThJ Il& Mdert•kiw, NRAS C￿tsn1ty Lyftrled. vp 19 3108¢4mbef 2Q24 thterwnwrry tran8K#mo. balJrKes l￿d UNt￿l￿d gm Ihe Clwrty rts •re eIn￿d ol JthlL•ry undert•kU￿ hav• dwr47gd rt•c•88•ry la •nsur llh I￿ pok• adopl•J by th• Gtwp. Thi ir￿c￿￿• of IlK• At th• ljmrj of apprw¥y ac£<ll￿ts, lh¢ TnJst••s fv•ve a feasonl •xprfl•bon thii th•ity adw￿1# r•iArw t4 ¢)FeraEM81 ex1%￿r￿¢ ih• for•8•e•l¥le lulure at tty12 Irom apPfO¥￿ ol Ih¢%¢ 5tto¥nts r • b&JeO iryffjtrnen¢J and c•sh posthcffj. mll•cbry • fjwlfKanl arnount of unr•sWg¢ fund• tr •cctsMrA. 1.J Ch•pllbb• lund• AF¥tybXed art •r• ¥afA1 ffi accOrd•r￿ spwnc re8trtlths d(#y¥ r￿d ty thtr th•rity for pvlKW•r ptjrpom. Tht eo1 Gl t•wg ￿mInfIr￿a such fund% •rn c•1￿ a911n￿ ru￿. Th• alm arNJ pf 8Bch fund IS •vt In nole8 to sl•i•ffjw 1A IrbG•mlnB rwuvc rv9nl￿J 4Ytt IM b•oD ￿1)1￿ & the rblfijs ￿rfo￿￿T￿l reguiM d￿e￿al pl fv ¥rnounL InccfThÈ rtovwJl• ￿ I￿￿1￿ ID 1¢￿1hxw Meknd urf•r 23

NATI0p￿ RHEUMATOID ARThRrrig SocErY P40FESTL) THEACCOUP4TS FDR T￿E YWI ENDEts 31 DECElJl&ER 2fy24 krw, 4FHI rec•pl il Thunl knfrhfi. th• trealqd al Vd fth15iWI ass ThB <arty QMnf¥ ffj T•¥>￿t ol &divilivs lh• £￿￿ty. lfictft Inm w¥nlS w• r￿n￿•S ￿lI1r 4r& tht chry •nIrtlofn￿t aéler any PtrtNm¥K• ha¥t tthl Il 0 I￿[￿1• I￿11￿ inxn• ￿11 bt ￿l¥¥j arity. fC•wd in IDf 1UPP￿1￿ &vx¥J¥ ¥•r¥K•s r ottlef Its WKI whrb 0•1￿• ytr¥ided nwnAI Iwsiws. n•1 Old￿Coun1￿ VA T •nd ¢ther rf•1•d Eax•s. IA It••wrf•• •xp•vthd •%p•fvfthr• 1$ lor oft •ft ttnAl bm• Iw• ba•n ¢1oWO urthr 11￿1 49feg4 •1 coèls rnl•lKI Eg thTr ¢•fpwry wh•r• Is 8 al at1w1￿ lo mak• p4ymertt$ 10 paths. cibly Ihal tho MI￿¢nI •ll b• r•4wwI •bWIl abthg•bw 1>• Th41urO tllabty. * i¥ ¢4LpJrywg urbJ•f Ih rolthvlr¥ )Yw18•• 8). rK4)vèr•blg VAT h chwwl •• •A •>p•fiM •9wthI Il •cbwty dIr￿ls￿￿T￿l ¢0¥• They ¥e M ncurr•d dirncty lutherry Of1￿ m•J• tor Ilw)fj• costs rel•l#)g ta th• r•l•ry of Ivvth lo gevwnw¢•. Tl bBJ•I on <¢fvB bmn &leatèd •1 wt h) N¢ •. FuTrar•i#rrry •r• 5hthd In tlote 7. E)P¥nth￿ ￿ ￿cl￿ntd for orn •n baw8 haj been wNJ•r * Ihat wrtgalt rfit•d tq 24

NATlOrtAL RHEUhlATOID ARTHRtns $(KEtY NDTES Tts Tr4E Accoufff3 FCIR THE VE4R ENDED 11 DECEMBER Z024 ￿tt￿rrtI￿ PDle• In 4.8 Inurylblv •￿1 l•nBhbh taN•d 21PA itrtr)M IM pwhxl * sl 25% 1tr&¥)ht I 25% strltphl kne FrA1LLtts. & equi￿1 Tmlw ol thè an￿1 ly roCOgnW kn T￿1 thctyrrfw•￿lllur•> y•w. 1.7 Imp•lrmw of fix•d ropw ei¥J d•ie. the tharity rtr•WS carryww rfs t4r4ibl• •5¥ts ty dlt¢rnine Wl￿1héff Ilw wwjicalw Ihtsl thos• 8sws svif¢red ￿ ffipoiffrlent h)s8. Il iTraKalKin wxts, th¢ reojyorablo arn￿￿1 45s•11s •slThTt•LI ITr k èll￿1 ol Ihtr •MPaifftWIl {K any). l.• C•¥h •rxl c•sh •4ufr¥alw cosfft IrK&J¢p c¥ft In h4￿J. dwills hok14l ull tr￿ks, 4th•1 $￿n.1•rn IJY•sblWJfits t)r¥ml rn•t￿ts￿ ol thrw or 1•>3. •nd b•nk ovtsdrafts. Bwk Ovwdw4ft• •ro vrflyn t)orr•tyiNJJ n tufgtni 1.9 short E•m In¥••tm•nl• ••r. 1.10 lrntrum•rt¥ Tha hay elected t<> ¥ply pro¥isvis ol S¢ckn 11 Bast F¥￿ddI IMinllYwl•' and S•dkn 12 frw? lh• h￿IruMO￿L Finarwl sJtsts and li•l>tlrtth w• off¥eL •wJnu firw￿la1 slBlerngrfs, i¥ • gnfortabl& io oll tm wvj • •n to Uillle oft a n•1 th• •Thy kètdrty sIMultar￿Sty 5bipJiys • irwshoft. whère I1￿ prwnl ol Ihe I￿11? focW5 4t r41• ¢Jl ITwrg. Fin•rwI ssètB dassme￿ •B liiw amortm 25

MA TIOMAL RHELIAIATOID ARThRms 50CI l¢OTE3 TO THE A¢￿U￿r5 FOR THE YEAR ENDED 31 DECEMBER XI24 BBait hblrtw. Inckkybig erKlits5 4fKI b￿k loo￿ Inib•ty unt￿& • rnwk•l of )¥tèsi pay4b tYO nLI Trd• crttlrtor ar• pay lor s¢rvw 1141 boon •C4ukn•d in th• ¢)pMt&￿l frgffl SUFpl4ir¥. AMI￿n￿ P¥rf4blp Jr• clas4i&d ¥ ewtsl Wil06 Il Payrnenl is duv withkn lèw If rkoc I￿Y pr5th7Ied as nonrurr•nl la￿1￿6. Tfioe rr•diw5 4r• tnnuckn prè 4r41 AI 1.11 Flx•d lryw••lrnfrfftl• •9901 ffj¥•5frnntB Arè tsitlavy rn6•wr•d at Iwi8&ebM pK• •¥cI￿ling tran8a¢tsrt &)d4s. at• subs•]￿ntrY mo8wr•d •1 lair v•bJo ￿ •ach I￿￿r￿a Chanw are wr4•d I1wnWI•XF￿VJ{•) for N ￿. TMr04C>2n 1.12 b•n•llts Th •Ay holKl•y •nbllwMnl is th• got￿ kn tathith •ef¥th rn¢¢fvJ. •M¢tyMrrts 01 •n ampkny•• or ¢0 IvrniTral￿ benefs. l.lj L•u•• paylo urrfl•r operbry knKSJ• iry IM•••K•nty•W• f•cthYd, •1• ¢th•rs•g +)n 4 ba rtr ol ihe 2 Crtiicol •cec+unfjrnL4 Mllmat•i Judp•rn&Thts 4rAiirryknRs •ttyyJI ￿￿y11¥ wrtsJN fA ass•l$ I￿j ilal nol r•WI aH)wtThl freth tAl￿r scwrr•5. Th •rbJ ass￿1￿1•d a55￿p1￿ att bad on hlstml aril olt•r14cn th•1 cmthf•d r•vafflL AthAI rèsults m•y drflw frtyn IPe •>lm•t•¥. i•coirwd ITr tho in fib¢h ••kniale IJ revi￿d t•r• ltr￿ *Yecls ffjty 9•rnd, ol lh•

TIOIAL RHEVMV4TOID mRITIS SOCETY r•DTE5 TO TMÉ AttDLIMTS FCA? TME YEIR EI¥DED 31 DECEMBER 2ts24 453A 788.7 561,5 JXI40A 1,242_1 PAs¢rred IwrKfs .141 7 1342.1 LfoJl.9 4 Pft¢thknè thwl¢•bl• acllvlli fyoup thity 23.3 16.0 105.3 217 29.2 716 Ilesefjrth Sluthes GrarWJ 115.9 210,9 Nèitrtt•d fur¥l¥ 4a7 J62.2 Zlthg 191_3 125.J S Ixher Xt1￿ GtyJg •ffld ¢hrfty 2QI4 202> t¢rthrth 4nd tr4dlr4VlfCffi 14S IP.5 4fpJ 2024 Kryro from Ilfftd Irrtstrr*r knrET¢rt irKorn 30.2

IIt>TE5 TD 714 AryQUhTS Ftm THE WA Iwtsltr •I tsÉCÉMBER (hwb 1024 7A 42 iTr.J 117.9 Il.J Il J 123 &2 10 J31A 1245 574 i)io 133.4 J4 2dl 293 1)17 73 IY>.7 ol x¥wt cosrj iw• r41M YJ 2Y12 1>4 OfJ Ji &7 41SI 14J 1r¢i*d 3).4 301.9 00 OD 2419 to. 49. LJ32 2 j.iiij 14LA

FOR T￿E IVOAO 2014 7A 242 17.9 275A oo 12.3 ui YYA 13.5 424.5 s?.4 77A aB¢J J37.U .233A 10>.7 ri evk E d gjpm COSts 9> 612 0£4 191.9 1119 39 2Y7 1S.4 tso 134 13.4 h%9 iisj Lk J119 415,3 745 2149 uii

5tsNusts %s Crflbt 1711 22.1 2fkS 41 Si.? IrrEcurfr¥AT 24.1 71ffj 51.7 17J 170 JJ 571.2 •36 $19 .J IJA 46 rty 2Wi JJ 303 97] 3&5 3rk5 17 24.> Irr¢¢ryhYr•b VAI 41. 51.7 SL7 Insur￿• 64 17J 17,3 t7JJ CAO 124 ssa •1 Fw&traI￿n1 Inore 113 i) 46.9 2842 JVA2

orts TO ThE ACCOUNTS FOR ThE YWÉ ENOED31 DEtthlkR 1014 11 EMpltyts Mumbr Thl •VEf¥e mtrnthty oltnwtQYW5 the All emLyffeJ. Grw and Chorrty 30 30 The a¥rr4Ke numbwd I￿$.t}me¢qU￿knI 0fflpkw￿duf￿￿ yelf 41., l ernplU￿5- 6ft)up Chirity 26 Group charty 1023 1023 Wate$ 4rd Jll¢s S¢csil securily 936,1 910,6 46.8 78.1 936.1 46.7 85.9 1.068.7 910.6 46 78.1 1,035 1,068.7 The t4xal DI reOwthrKY P￿rne￿5 mède by the C4xnp•ny in th¢ywr w45 £1.346121)23'. ￿.1￿) lkn number ol empltyées who r¢ceYv•d 1014 ernpe benefits (e*cl¥dlry¢fflplry¥tr wniiw cos1$1 ol more thJTr E60.IJKI is s follo4￿. Plwib £70m. £80.4 R•muTw4ilw ol ke¥ fflDwerMnt p•rsowil Thq rornbJnw4lron 0¢ key rMrt•6wwni p￿5￿nF￿1 ts a5 loll0￿.. 14).4 184.9 Ji

IIATiofiAL 4vrHR11155<K PIWE5 TO TME ACCOUMTS

OR YbÉYE4R ENDED 31 DEUMBER2fr14

A1￿lu1[￿ 11 IJM44 ￿de￿arIlY T￿1 At JI IOU 4J 25 s&? AI 31 DEcvnhr 2014 134.8 15.8 Al 31 Derember 2023 4LI 47.15 21.1 Dlwls AI 31 December 2024 130.6 11.6 At 31 Eii¢wfvber ZOII 14.1 Al 31 Dxember 2023 19A 17 Xg 2021 U51•d P41jrk￿ Vilue at i january LIK￿5 32,3 91ZS ￿t￿luat 65• 1th.3 kn#tvmw15 ffteaJLtred at c￿1 ot tsir thrwh profil or I 424 a55,Z arryknr ol hI￿lUred

14C)TES T¢tTHE AfCQUPIT5 FI YEAR ENt>EO 311)ÉCÉhkÉA 2Q24 J6 n15 •lllw &J• ?,0 17,7 0.0 337.5 i?,y Ammtj tr•rnl try BwunLrtakiry5 75,4 JJ?.s 48 46 40 drtfl4x3 Irxlude E25.3k felèiiry tErrn thL1ry5 rK¥vable lft Wterth￿ ¥￿$ Ch￿ty 20Z4 Z013 2024 2023 T[￿+ crtdrt Other wclll $￿￿rtty ¢osts Is.¥ 17.7 SS.7 7A iu 17.7 55,T 25 44.2 33_1 12S.2 •7A 114.7 1024 DelerrEd kncc¥r the dbwKlal ststements•i 101104¥S: l J JIM￿ry 14to¥em•nt dur1￿ IhE ye•ff 131 Oe¢ember [3.& 13.8 11 H•ik•rnMI b•n•fii Jthom Jtherns The Clhty owr•t•s I ￿hètht lor I114wMyln4 The 05ts Icthe￿ thiryÈ its loss ol dofjned<OMrlb￿ w1 É46.Th12023'. £4&lk

INE￿AT￿￿ IIS TO THÈ Accol￿$ YEAR EIIDt¢ li Ol¢ÉpAIÉII 2ts24 l•nu¥ry 2014 1034 aoa UOPQ (L479.61 tbwnat•Y. Oper￿1￿ ID n•rf 13A7J 112481 5faO 57%] Icoo 25¢ Ico IMJ) srAo L997A IL51 J•mMrylQ2J 20 2021 LJ09.1 IX193 ILJ6U [513) 14t&BI JLAWNb ItNopaEhk Anfvrrtls •cti 375.0 [n￿0. lu <thyp mlertlll rnstrr•Ent Icor L•lg,1 L•97A 1024 ]o]i 11.4 14.81 ¢15.Jl 11.41 AJ IlJJkn proJEa Q t4b prnlEtt 15h 4tw¥ I￿ 24 I￿rI 2QX 136.fii 2023 i {116 Q7 UIS IL,J QD lis IIOA 15.11

NAiIDfw IiiiEWTOIts ARTHRITIS SOCIEr riDTE5 TO THE A¢¢OUNIS FOR THE VÉAk EItsED 31 DECEMBER 1024 Fund at 31 DtÉthr 2fy24 •r•f•pfow•tod br. p4.8 LQ¥J.Y 28, I,1)39.a CwT¢rrt 20,1 1.02LJ 2W.4 Fund •t JI Ci•E•fflbw IOZ3 ** rw•s•nW bv: Toi 36.9 L4IJ&5 9721 In¥e5tr)Èth C4ffrtrbt 4sts1WblWh5} ,0 ?o.o LL¥I6.5 952LI IJ97A lJJ17,4 fttstrt¢ted urtrtKrk￿d Totil Fuhd bal￿5 4¢ 31 Dwember 1024 br. T3nthbt Irxed 4Mets 28 Im3.3 897.9 J.Q93.3 Cwrnnr a$5oisllll•bifftF¢sJ 21IA lQ26.0 IL116.1 rund bthrK•s •t 31 ￿tt&￿ber 2013 r•pr•wnied bv: R4StrI¢l￿ ikrfostrlcltd T¥ng￿le knd assets InvutrhÈnE5 C4Mreffll 36.9 I,QXX.5 gS4.7 36.9 974.7 20.0 cw.I 1020.1 11 under f9￿15 At fep)rtlr nd the Onrfl ehorSiy had cornrnftments for luturt nkn¥num nd￿ non•rK•ll•bJ opwa 4¥hkh fll 15 f(kni 2024 1023 lthln 47.6 t4vo IE¥e year3 y¢4 17_9

HITIONAL •HEUktAttsD ARTHRMS WEr¥ NOTES TO THE ￿0(￿P￿S FOR YEIA El•DW 31 LIECEMBER 2024 21 SubJMW rprnpony Ihapfty 044flS th¢ wholE of tFhE ts&u￿ Ordin•ry 5h4re c4ptsI of NRAS CthTwnlty st￿CeS Ltd Icompaty rtunthÈr.' 895)24 jl, a comparty re61sf¢r¢d * en¢•nd. Thé Subithary Is wqd for ￿￿-￿IMarY Purp05¢ tr•dtr¥ 4ctFvltle5. All 4tt14ltlES bth Dn a kne b•ys In tho atemeM ol fknnciJl •ttrltlq5, A swrtrr¥ry of tsl th 15 ￿1C￿. 24 ID13 Twrthr Cost 5o1ES Gross prrfil 0.0 lt prrf ID.J] Attal￿d qarnp bro￿ht Its￿•rd Glft •kl to Niih)Ml Arthdtls Soclety Réuined e4rnlr45 carrled for￿rd In sthJwy 11,7 iuj L7 11.7 T￿ uspts lia￿lIE1t$ werE'. The 8Vryèt• ol the 45sets. f￿1111$ Ind fvftd5 biiifies Totsl net assets 13.11 11.7) ii.?J cal￿ ￿ shareupiul Prolli and loss 0.0 12. (2.71 13 Ild•i•d yrty tr4nJ•ttlty w•re fftlated p•rty ¢rafftSa¢iths In the year12023: nll r•qulrfTht dlthwe. Iq C•plld Commllrnen A5 il 31 Dttenxr 2014 Ih? Chartty had ￿P￿lI ¢omTrthTrts ol Éfil12023: Énll. 36

NAnoNAL RHEiIMATOIE• AknIRm5 5IXIETY NOTESTOThE ACCOUPfS FQR THÈ VEAII ENDED YI DECEMBER 2Q24 2S C1 Irgrnl Iu5ed Inl QP•Walipn5 Charftv 2024 1023 2024 Svrplu51 IIDssJ for the ￿ar Adju51men15 for,. lrtwtstrnent lTrcorfw rtni5ed in profft Or loss F4tr w￿ 6aln5 3Thd 1gtse5 on •iivestments Gilt •id dunatlon ffwrt Sub5ithry Depre¢iarioTr and imprYrtent of intarylbk fix¢d 455et Depte¢iatiDn and Impairmtnl of tan#ble fix¢d as%e15 I￿￿em¢n￿l￿ ¢aptcal', Ilncreas¢V deirease Indebio IKreasel Ipjecreasel In uedlltys 403.9 26.0 (59.11 (58.5J 134.7) {59.11 154.51 134,71 165,8] 21.3 14.3 33.6 18.1 21.8 14.3 i&1 274.S {27_8) 16.11 9.0 2769 1273 16.11 C•h Inl oper&tsns 191.5 358.0 194,1 359 16 Anilw3iS vl th￿8*$ In n•1 l(•nd% Al start of Cash flow+s At end af ir Cash and ush tquivalents 667.4 14>.4 618.0 Tot•1 667.4 {49.41 61&0 37